BSE Live
Jan 01, 16:01Prev. Close
41.07
Open Price
40.50
Bid Price (Qty.)
41.08 (20)
Offer Price (Qty.)
41.18 (764)
NSE Live
Jan 01, 15:58Prev. Close
41.07
Open Price
41.07
Bid Price (Qty.)
41.11 (233)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Morepen Laboratories (in Rs. Cr.) | Mar 05 | |
| 18 mths | ||
| EQUITIES AND LIABILITIES | ||
| SHAREHOLDER'S FUNDS | ||
| Equity Share Capital | 30.20 | |
| Total Share Capital | 52.50 | |
| Reserves and Surplus | 183.50 | |
| Total Reserves and Surplus | 183.50 | |
| Total Shareholders Funds | 236.00 | |
| NON-CURRENT LIABILITIES | ||
| Long Term Borrowings | 664.58 | |
| Deferred Tax Liabilities [Net] | 168.34 | |
| Other Long Term Liabilities | 0.00 | |
| Long Term Provisions | 0.00 | |
| Total Non-Current Liabilities | 832.92 | |
| CURRENT LIABILITIES | ||
| Short Term Borrowings | 279.58 | |
| Trade Payables | 52.28 | |
| Other Current Liabilities | 1.50 | |
| Short Term Provisions | 1.20 | |
| Total Current Liabilities | 334.57 | |
| Total Capital And Liabilities | 1,410.09 | |
| ASSETS | ||
| NON-CURRENT ASSETS | ||
| Tangible Assets | 678.61 | |
| Intangible Assets | 0.00 | |
| Capital Work-In-Progress | 0.00 | |
| Other Assets | 0.00 | |
| Fixed Assets | 678.61 | |
| Non-Current Investments | 71.21 | |
| Deferred Tax Assets [Net] | 192.78 | |
| Long Term Loans And Advances | 0.00 | |
| Other Non-Current Assets | 6.41 | |
| Total Non-Current Assets | 949.01 | |
| CURRENT ASSETS | ||
| Current Investments | 0.00 | |
| Inventories | 79.73 | |
| Trade Receivables | 143.03 | |
| Cash And Cash Equivalents | 69.46 | |
| Short Term Loans And Advances | 150.62 | |
| OtherCurrentAssets | 18.24 | |
| Total Current Assets | 461.08 | |
| Total Assets | 1,410.09 | |
| OTHER ADDITIONAL INFORMATION | ||
| CONTINGENT LIABILITIES, COMMITMENTS | ||
| Contingent Liabilities | 0.00 | |
| CIF VALUE OF IMPORTS | ||
| Raw Materials | 18.21 | |
| Stores, Spares And Loose Tools | 0.00 | |
| Trade/Other Goods | 0.00 | |
| Capital Goods | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||
| Expenditure In Foreign Currency | 2.50 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||
| Dividend Remittance In Foreign Currency | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||
| FOB Value Of Goods | 86.88 | |
| Other Earnings | -- | |
| BONUS DETAILS | ||
| Bonus Equity Share Capital | -- | |
| NON-CURRENT INVESTMENTS | ||
| Non-Current Investments Quoted Market Value | 0.77 | |
| Non-Current Investments Unquoted Book Value | 71.01 | |
| CURRENT INVESTMENTS | ||
| Current Investments Quoted Market Value | -- | |
| Current Investments Unquoted Book Value | -- |
26.11.2025
Morepen Lab Consolidated September 2025 Net Sales at Rs 411.58 crore, down 5.97% Y-o-Y
24.11.2025
Morepen Lab Standalone September 2025 Net Sales at Rs 369.53 crore, down 3.69% Y-o-Y
12.08.2025
Morepen Lab Consolidated June 2025 Net Sales at Rs 425.24 crore, down 6.59% Y-o-Y
07.08.2025
Morepen Lab Standalone June 2025 Net Sales at Rs 391.28 crore, up 1.46% Y-o-Y
26.11.2025
Morepen Lab Consolidated September 2025 Net Sales at Rs 411.58 crore, down 5.97% Y-o-Y
24.11.2025
Morepen Lab Standalone September 2025 Net Sales at Rs 369.53 crore, down 3.69% Y-o-Y
12.08.2025
Morepen Lab Consolidated June 2025 Net Sales at Rs 425.24 crore, down 6.59% Y-o-Y
07.08.2025
Morepen Lab Standalone June 2025 Net Sales at Rs 391.28 crore, up 1.46% Y-o-Y